Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.

被引：0
|
作者：
Lyman, GH
Bernal, M
Badamgarav, E
Pinto, L
Dubois, RW
机构：
[1] Univ Rochester, Dept Med, Rochester, NY 14627 USA
[2] Zynx Hlth Inc, Beverly Hills, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4393
引用
收藏
页码：170B / 171B
页数：2
相关论文
共 50 条
  • [1] Treatment of febrile neutropenia: filgrastim and pegfilgrastim
    Franco-Trigo, Lucia
    Angel Calleja-Hernandez, Miguel
    Garcia-Corpas, Jose P.
    ARS PHARMACEUTICA, 2014, 55 (01) : 2 - 7
  • [2] Study of Cost-Benefit of Prophylactic Treatment of Febrile Neutropenia with Pegfilgrastim vs. Filgrastim in Paediatric Patients with Solid Tumors
    Araceli, L.
    Tejocote Romero, I.
    Jaimes Garcia, Y.
    Rodriguez Castillejos, C.
    Garcia Espinoza, A. C.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S272 - S272
  • [3] Cost effectiveness of pegfilgrastim vs filgrastim for febrile neutropenia(FN) prevention in breast cancer patients
    Danova, M.
    Rosti, G.
    Dubois, R. W.
    Chiroli, S.
    ANNALS OF ONCOLOGY, 2007, 18 : 38 - 38
  • [4] Breakthrough febrile neutropenia after the use of pegylated filgrastim (pegfilgrastim): Incidence and risk factors
    Ahmad, I.
    AbdulRahman, K.
    Zekri, J.
    Karim, S.
    AbdelGhany, E.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S233 - S233
  • [5] Cost comparison of filgrastim versus pegfilgrastim and pegfilgrastim biosimilars for inpatient prophylaxis of febrile neutropenia
    Singer, Kaeli
    Forshay, Charlotte M. M.
    Kennerly-Shah, Julie
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1695 - 1701
  • [6] Optimizing the use of colony stimulating factors in reducing the risk of febrile neutropenia.
    Dubois, RW
    Badamgarav, E
    Bernal, M
    Song, P
    Lyman, GH
    BLOOD, 2003, 102 (11) : 169B - 170B
  • [7] The economics of febrile neutropenia.
    Lyman, GH
    Kuderer, NM
    Green, J
    BLOOD, 1996, 88 (10) : 1374 - 1374
  • [8] Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients
    Chan, Alexandre
    Leng, Xue Zhen
    Chiang, Joen Y. L.
    Tao, Miriam
    Quek, Richard
    Tay, Kevin
    Lim, Soon Thye
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (01) : 75 - 81
  • [9] Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim
    Lee, Mirinae
    Yee, Jeong
    Kim, Jae Youn
    Kim, Ju Young
    An, Sook Hee
    Lee, Kyung Eun
    Gwak, Hye Sun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (04) : 231 - 237
  • [10] Risk factors for readmission in patients admitted for febrile neutropenia.
    Van Klein, Justin
    Gillis-Smith, Andrew J.
    Slotkin, Rebecca
    Reagan, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345